These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6835036)

  • 1. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals.
    Mukhopadhyay A; Patel ST; O'Brien M; Kokrady SS; Newman HA; Witiak DT; Lanese RR; Rice JC; Feller DR
    Lipids; 1983 Jan; 18(1):59-67. PubMed ID: 6835036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.
    Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT
    Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
    Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
    Ståhlberg D; Angelin B; Einarsson K
    J Lipid Res; 1989 Jul; 30(7):953-8. PubMed ID: 2794793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoprotein and apoprotein concentrations in 4-(4-chlorophenyl)-2-hydroxytetronic acid and clofibrate-treated cholesterol and cholic acid-fed rats.
    Kamanna VS; Newman HA; Patel ST; Tehim AK; Witiak DT; Feller DR
    Lipids; 1989 Jan; 24(1):25-32. PubMed ID: 2747427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and of acyl coenzyme A:cholesterol acyltransferase by dietary fat.
    Mitropoulos KA; Venkatesan S; Balasubramaniam S
    Biochim Biophys Acta; 1980 Aug; 619(2):247-57. PubMed ID: 7407210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
    Purdy BH; Field FJ
    J Clin Invest; 1984 Aug; 74(2):351-7. PubMed ID: 6746898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase and of acyl-CoA--cholesterol acyltransferase by the transfer of non-esterified cholesterol to rat liver microsomal vesicles.
    Mitropoulos KA; Venkatesan S; Reeves BE; Balasubramaniam S
    Biochem J; 1981 Jan; 194(1):265-71. PubMed ID: 7305980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cholesterol, lecithin-cholesterol acyltransferase, and hepatic hydroxymethylglutaryl coenzyme A reductase activities of lean and obese Zucker rats.
    Lin RC
    Metabolism; 1985 Jan; 34(1):19-24. PubMed ID: 3965858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats.
    Goldberg AP; Mellon WS; Witiak DT; Feller DR
    Atherosclerosis; 1977 May; 27(1):15-25. PubMed ID: 857813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of clofibrate on plasma lecithin: cholesterol acyltransferase (LCAT) activity in rats.
    Cisternas JR
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):317-24. PubMed ID: 531275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary fat-dependent changes in hepatic cholesterogenesis and the activity of 3-hydroxy-3-methylglutaryl-CoA reductase in fasted-refed rats.
    Ide T; Tanaka T; Sugano M
    J Nutr; 1979 May; 109(5):807-18. PubMed ID: 438898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model.
    Witiak DT; Heilman WP; Sankarappa SK; Cavestri RC; Newman HA
    J Med Chem; 1975 Sep; 18(9):935-42. PubMed ID: 1159716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate.
    Phornchirasilp S; Patel ST; Hanson JM; Newman HA; Witiak DT; Feller DR
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):139-46. PubMed ID: 2726779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver.
    Berndt J; Gaumert R; Still J
    Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase. The difference in the mechanism of the in vitro modulation by phosphorylation and dephosphorylation to modulation of enzyme activity by non-esterified cholesterol.
    Venkatesan S; Mitropoulos KA
    Biochim Biophys Acta; 1982 Mar; 710(3):446-55. PubMed ID: 7074124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis.
    Parthasarathy S; Kritchevsky D; Baumann WJ
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6890-3. PubMed ID: 6294663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.